Quick Takeaways
- Garry A. Nicholson has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Garry A. Nicholson
- Location
- Waltham, MA
- Signature
- /s/ Charles N. York II, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Garry A. Nicholson and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: G1 Therapeutics, Inc. ($0).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Garry A. Nicholson
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| GTHX | G1 Therapeutics, Inc. | Director | $0 | 18 Sep 2024 | ||
| DAWN | Day One Biopharmaceuticals, Inc. | Director | 06 Nov 2025 | |||
| NXTC | NextCure, Inc. | Director | 22 Jun 2023 | |||
| TCRX | TScan Therapeutics, Inc. | Director | 30 Jun 2025 | |||
| TPTX | Turning Point Therapeutics, Inc. | Director | 17 Aug 2022 |
Insider Transactions Reported by Garry A. Nicholson:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.